[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4096 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 4096

To amend title XIX of the Social Security Act to expand the application 
of Medicaid State programs to monitor antipsychotic medications to all 
                        Medicaid beneficiaries.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             June 14, 2023

 Mr. Carter of Georgia (for himself and Ms. Schakowsky) introduced the 
   following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
To amend title XIX of the Social Security Act to expand the application 
of Medicaid State programs to monitor antipsychotic medications to all 
                        Medicaid beneficiaries.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. EXPANDING APPLICATION OF MEDICAID STATE PROGRAMS TO MONITOR 
              ANTIPSYCHOTIC MEDICATIONS TO ALL MEDICAID BENEFICIARIES.

    Section 1902(oo) of the Social Security Act (42 U.S.C. 1396a(oo)) 
is amended--
            (1) in paragraph (1)(B)--
                    (A) in the subparagraph header, by striking ``by 
                children'';
                    (B) by inserting ``, and, beginning January 1, 
                2024, by individuals (regardless of age) enrolled,'' 
                after ``children enrolled''; and
                    (C) by striking ``for individuals not more than the 
                age of 18 years generally and children in foster care 
                specifically'' and inserting ``, including for 
                individuals not more than the age of 18 years 
                generally, children in foster care specifically, and, 
                beginning January 1, 2024, individuals over the age of 
                65, individuals receiving home and community-based 
                services (as defined in section 9817(a)(2) of Public 
                Law 117-2), and individuals residing in institutional 
                care settings, including nursing facilities and 
                intermediate care facilities for individuals with 
                intellectual disabilities''; and
            (2) in paragraph (3)--
                    (A) in subparagraph (A)(ii), by striking ``is a 
                resident'' and inserting ``subject to subparagraph (C), 
                is a resident''; and
                    (B) by adding at the end the following new 
                subparagraph:
                    ``(C) Application in case of program to monitor 
                antipsychotic medications.--Subparagraph (A)(ii) shall 
                not apply to the drug review and utilization 
                requirement described in subparagraph (1)(B) with 
                respect to an individual 18 years of age or older.''.
                                 <all>